1. 095 Remyelination in people with MS due to an RXR agonist is age-dependent. Issue 6 (27th May 2022) Authors: McMurran, Christopher; Mukherjee, Trisha; William Brown, J; Michell, Andrew; Coles, Alasdair; Cunniffe, Nick Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1 The neurological, psychiatric and theological significance of mystical seizures. (28th May 2019) Authors: Coles, Alasdair Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90(2019)Supplement 2 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 8. False positive mumps serology in a patient with cerebral systemic lupus erythematosus. (20th September 2018) Authors: Hammad, Adnan; Coles, Alasdair; Gibson, Mark D J Journal: Rheumatology advances in practice Issue: Volume 2(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ALEMTUZUMAB IMPROVES 3-YEAR QUALITY OF LIFE IN CARE-MS II. Issue 11 (14th October 2015) Authors: Coles, Alasdair; Giovannoni, Gavin; Moreau, Thibault; Havrdova, Eva; Margolin, David; Kasten, Linda; Singer, Barry Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 86:Issue 11(2015) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects. (May 2013) Authors: Kousin-Ezewu, Onajite; Coles, Alasdair Journal: Therapeutic advances in chronic disease Issue: Volume 4:Number 3(2013) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ALEMTUZUMAB PERSISTENTLY SLOWS BRAIN VOLUME LOSS IN RRMS. Issue 12 (15th November 2016) Authors: Coles, Alasdair; Arnold, Douglas; Barkhof, Frederik; Filippi, Massimo; Hartung, Hans-Peter; Havrdova, Eva; Selmaj, Krzysztof; Margolin, David; Thangavelu, Karthinathan; Schippling, Sven Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 87:Issue 12(2016) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy. Issue 2 (21st May 2014) Authors: Tuohy, Orla; Costelloe, Lisa; Hill-Cawthorne, Grant; Bjornson, Ingunn; Harding, Katharine; Robertson, Neil; May, Karen; Button, Tom; Azzopardi, Laura; Kousin-Ezewu, Onajite; Fahey, Michael T; Jones, Joanne; Compston, D Alastair S; Coles, Alasdair Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 86:Issue 2(2015) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. An evolving case of headaches and strokes. Issue 2 (8th March 2011) Authors: Shah, Amit J; Breen, David P; Thomas, David; Cross, Justin; Coles, Alasdair; Molyneux, Paul Journal: Practical neurology Issue: Volume 11:Issue 2(2011) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study. Issue 2 (3rd December 2018) Authors: Ellis, Joanne; van Maurik, Andre; Fortunato, Lea; Gisbert, Sophie; Chen, Keguan; Schwartz, Ann; McHugh, Simon; Want, Andrew; Santos Franco, Sara; Oliveira, Joao‐Joaquim; Price, Jeffrey; Coles, Alasdair; Brown, Kim; Su, Donggang; Craigen, Jenny L.; Yang, Jiansong; Brett, Sara; Davis, Bill; Cheriya... Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 2(2019) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis. Issue 4 (22nd June 2015) Authors: Scolding, Neil; Barnes, David; Cader, Sarah; Chataway, Jeremy; Chaudhuri, Abhijit; Coles, Alasdair; Giovannoni, Gavin; Miller, David; Rashid, Waqar; Schmierer, Klaus; Shehu, Abdullah; Silber, Eli; Young, Carolyn; Zajicek, John Journal: Practical neurology Issue: Volume 15:Issue 4(2015) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗